Mary Cosenza

Title(s)Voluntary Faculty
SchoolUSC School of Pharmacy
Address1540 Alcazar Street
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Classic and evolving approaches to evaluating cross reactivity of mAb and mAb-like molecules - A survey of industry 2008-2019. Regul Toxicol Pharmacol. 2021 Apr; 121:104872. MacLachlan TK, Price S, Cavagnaro J, Andrews L, Blanset D, Cosenza ME, Dempster M, Galbreath E, Giusti AM, Heinz-Taheny KM, Fleurance R, Sutter E, Leach MW. PMID: 33485926.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    2. Toxicology Paradise: Sorting Out Adverse and Non-adverse Findings in Animal Toxicity Studies. Int J Toxicol. 2020 Sep/Oct; 39(5):365-378. Baldrick P, Cosenza ME, Alapatt T, Bolon B, Rhodes M, Waterson I. PMID: 32618214.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    3. Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF in rhesus monkeys. Toxicol Pathol. 2007 Dec; 35(7):1013-29. Hovland DN, Boyd RB, Butt MT, Engelhardt JA, Moxness MS, Ma MH, Emery MG, Ernst NB, Reed RP, Zeller JR, Gash DM, Masterman DM, Potter BM, Cosenza ME, Lightfoot RM. PMID: 18098052.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    4. Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) in rhesus monkeys. Toxicol Pathol. 2007 Aug; 35(5):676-92. Hovland DN, Boyd RB, Butt MT, Engelhardt JA, Moxness MS, Ma MH, Emery MG, Ernst NB, Reed RP, Zeller JR, Gash DM, Masterman DM, Potter BM, Cosenza ME, Lightfoot RM. PMID: 17763282.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    5. Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers. Toxicol Pathol. 2005; 33(3):343-55. Thukral SK, Nordone PJ, Hu R, Sullivan L, Galambos E, Fitzpatrick VD, Healy L, Bass MB, Cosenza ME, Afshari CA. PMID: 15805072.
      View in: PubMed   Mentions: 23     Fields:    Translation:Animals
    6. A toxicity profile of osteoprotegerin in the cynomolgus monkey. Int J Toxicol. 2003 Sep-Oct; 22(5):403-12. Smith BB, Cosenza ME, Mancini A, Dunstan C, Gregson R, Martin SW, Smith SY, Davis H. PMID: 14555415.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals